|Last Price$4.17||Day Change (%)-0.24%|
|Open Price$4.23||Day Change ($)-0.01|
|Day Range4.16–4.26||52-Week Range3.26–7.97|
As of Fri 11/21/2014 05:00 PM EST | USD
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl
Arena Pharmaceuticals' future depends on its late-stage obesity drug.